Skip to main content
ADHERIUM LIMITED logo

ADHERIUM LIMITED — Investor Relations & Filings

Ticker · ADR ISIN · AU000000ADR1 ASX Manufacturing
Open in API
Filings indexed 878 across all filing types
Latest filing 2015-08-27 Regulatory Filings
Country AU Australia
Listing ASX ADR

About ADHERIUM LIMITED

https://www.adherium.com

Adherium Limited is a digital health company specializing in the development and commercialization of connected medical devices and software solutions for chronic respiratory management. The company's primary offering is the Hailie® platform, which consists of advanced sensors that attach to various inhaler medications to monitor usage and technique. These sensors transmit data via Bluetooth to a mobile application and a cloud-based portal, providing patients and healthcare providers with real-time insights into medication adherence and respiratory health trends. By facilitating remote patient monitoring and data-driven clinical decisions, Adherium aims to improve health outcomes for individuals living with asthma and chronic obstructive pulmonary disease (COPD). The platform is utilized by healthcare systems, pharmaceutical companies, and clinical research organizations to enhance patient engagement and optimize treatment efficacy.

Recent filings

Filing Released Lang Actions
Becoming a substantial holder 5 pages 166.5KB
Regulatory Filings
2015-08-27 English
Replacement Appendix 3B 10 pages 353.8KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the class of securities, number issued, issue price, purpose, and quotation application to the ASX (Australian Securities Exchange). It references specific ASX rules (2.7, 3.10.3, 3.10.4, 3.10.5) and includes sections typical of a new issue announcement form used in Australian market disclosures. The content is focused on the announcement and application for quotation of additional securities rather than a financial report or earnings release. This matches the definition of a Share Issue/Capital Change announcement, which covers new share issues and capital changes.
2015-08-27 English
Form 603 - Initial Substantial Holder 54 pages 965.0KB
Regulatory Filings
2015-08-27 English
Appendix 3X 2 pages 214.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including unlisted options and other securities holdings. This type of document is a report of personal share transactions or holdings by a company director. It is not an annual report, earnings release, or any other financial report. It specifically matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is short and focused solely on director interests, confirming it is not a broader report or announcement.
2015-08-25 English
Becoming a substantial holder 11 pages 382.9KB
Regulatory Filings
2015-08-25 English
Becoming a substantial holder 7 pages 265.5KB
Regulatory Filings
2015-08-25 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.